December was another busy month in the world of psychedelic research as 2021 came to a close. The benefits of microdosing remain in dispute, the use of virtuality reality in tandem with psychedelics is further discussed, and we gained further insight as to how different psychedelics work in the brain for different disorders through both experiments and reviews. One of the most interesting studies…


Previous articleRevive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
Next articlePT285 – Andrew Penn, NP – The Need for Nurses in Psychedelics, The Placebo Effect, and Appreciating the Subtle